Brief: Galapagos H1 Revenue EUR 140.3 Million
23/07/2025 21:01
Jul 23 (Reuters) - Galapagos H1 net income EUR -259.1 million. H1 cash & investments EUR 3,091.5 million
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
Brief: Lakefront Receives Transparency Notification From Bank Of America
Belgium's Galapagos Q1 revenue falls 91% but returns to profit
Brief: Galapagos, Gilead Enter Binding Agreement On Ouro Medicines Acquisition
Brief: Galapagos Announces Nomination Of Gino Santini To Its Board Of Directors